Health Alert:

See the latest Coronavirus Information including vaccinations, testing sites, visitation restrictions, and more.

Why Choose Penn?

Doctors writing notes on glass

As a world leader in cancer care and research, Penn Medicine's Abramson Cancer Center offers cutting-edge treatments for gynecologic cancers, including gestational trophoblastic neoplasia (GTN). We focus on both your physical and emotional well-being to provide the best outcomes possible. Our cancer specialists’ expertise and experience have earned us consistent recognition, landing our hospitals on the U.S. News & World Report Honor Roll for excellence in Cancer and Gynecology.

We’re Experienced in Care that Preserves Fertility

Our gynecologic cancer specialists work with Penn Fertility Care specialists to create customized gestational trophoblastic disease (GTD) treatment plans that can help you build a family after treatment. This is often called a “fertility sparing approach” or “medical management” of cancer and other diseases that can affect the reproductive organs.

Our Cancer Care is Collaborative

We have more full-time, board-certified gynecologic oncologists than any other hospital in the Philadelphia region. Our entire team, including medical oncologists, pathologists, surgeons and radiation specialists, meets weekly to discuss joint treatment plans for each of our unique patients. However, GTD and its treatment can affect the whole body. That’s why we partner closely with specialists throughout the Penn system: This collaborative model lets us take on a greater complexity of care.